Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 31

Related Articles by Review for PubMed (Select 22540172)

1.

No autoimmune safety signal after vaccination with quadrivalent HPV vaccine Gardasil?

Tomljenovic L, Shaw CA.

J Intern Med. 2012 Nov;272(5):514-5; author reply 516. doi: 10.1111/j.1365-2796.2012.02551.x. Epub 2012 May 24. No abstract available.

PMID:
22540172
3.

HPV vaccines and pregnancy: the situation in early 2012.

[No authors listed]

Prescrire Int. 2012 Jun;21(128):154-7. Review.

PMID:
22822594
4.

Efficacy of human papillomavirus vaccines: a systematic quantitative review.

Medeiros LR, Rosa DD, da Rosa MI, Bozzetti MC, Zanini RR.

Int J Gynecol Cancer. 2009 Oct;19(7):1166-76. doi: 10.1111/IGC.0b013e3181a3d100. Review.

PMID:
19823051
5.

Human papillomavirus vaccines.

Schmiedeskamp MR, Kockler DR.

Ann Pharmacother. 2006 Jul-Aug;40(7-8):1344-52. Epub 2006 Jul 18. Review.

PMID:
16849621
6.

Assessing human papillomavirus vaccine efficacy and safety.

Hendrix SL.

J Am Osteopath Assoc. 2008 Apr;108(4 Suppl 2):S8-S12. Review.

PMID:
18463363
7.

Developing an HPV vaccine to prevent cervical cancer and genital warts.

Bryan JT.

Vaccine. 2007 Apr 20;25(16):3001-6. Epub 2007 Jan 18. Review.

PMID:
17289220
8.

The quadrivalent human papillomavirus vaccine: potential factors in effectiveness.

Zonfrillo NJ, Hackley B.

J Midwifery Womens Health. 2008 May-Jun;53(3):188-94. doi: 10.1016/j.jmwh.2007.12.015. Review.

PMID:
18455092
9.

The prophylactic role for the human papillomavirus quadrivalent vaccine in males.

Yancey AM, Pitlick JM, Forinash AB.

Ann Pharmacother. 2010 Jul-Aug;44(7-8):1314-8. doi: 10.1345/aph.1P017. Epub 2010 May 25. Review.

PMID:
20501891
10.

Human papillomavirus disease and vaccines.

Hutchinson DJ, Klein KC.

Am J Health Syst Pharm. 2008 Nov 15;65(22):2105-12. doi: 10.2146/ajhp070627. Review.

PMID:
18997137
11.

Primary prevention of cervical cancer: prophylactic human papillomavirus vaccines.

Mandic A.

J BUON. 2012 Jul-Sep;17(3):422-7. Review.

PMID:
23033276
12.
13.

Clinical update of the AS04-adjuvanted human papillomavirus-16/18 cervical cancer vaccine, Cervarix.

Schwarz TF.

Adv Ther. 2009 Nov;26(11):983-98. doi: 10.1007/s12325-009-0079-5. Epub 2009 Dec 18. Review.

PMID:
20024678
14.

Quadrivalent human papillomavirus (HPV) types 6, 11, 16, 18 vaccine: for the prevention of genital warts in males.

Garnock-Jones KP, Giuliano AR.

Drugs. 2011 Mar 26;71(5):591-602. doi: 10.2165/11205980-000000000-00000. Review.

PMID:
21443282
15.

Quadrivalent human papillomavirus recombinant vaccine: the first vaccine for cervical cancers.

Sharma R, Sharma CL.

J Cancer Res Ther. 2007 Apr-Jun;3(2):92-5. Review.

16.

Human papillomavirus and the HPV vaccine: are the benefits worth the risks?

Knudtson M, Tiso S, Phillips S.

Nurs Clin North Am. 2009 Sep;44(3):293-9. doi: 10.1016/j.cnur.2009.06.005. Review.

PMID:
19683091
17.

Human papillomavirus quadrivalent (types 6, 11, 16, 18) recombinant vaccine (Gardasil).

Siddiqui MA, Perry CM.

Drugs. 2006;66(9):1263-71; discussion 1272-3. Review.

PMID:
16827602
18.

HPV-vaccination against cervical carcinoma: will it really work?

Gross G.

Med Microbiol Immunol. 2007 Sep;196(3):121-5. Epub 2007 Feb 21. Review.

PMID:
17318575
19.

Preventive and therapeutic HPV vaccines.

Monie A, Hung CF, Wu TC.

Curr Opin Investig Drugs. 2007 Dec;8(12):1038-50. Review.

PMID:
18058574
20.

Post-licensure monitoring of HPV vaccine in the United States.

Markowitz LE, Hariri S, Unger ER, Saraiya M, Datta SD, Dunne EF.

Vaccine. 2010 Jul 5;28(30):4731-7. doi: 10.1016/j.vaccine.2010.02.019. Epub 2010 Feb 25. Review.

PMID:
20188681
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk